Sign in
4

Changes in Ownership

enGene Therapeutics Inc. Filed Acc 0000929638-24-002002

Director acquired 120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Glickman Richard M · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-28 Exercise or conversion : show line 1 in the form +120 $0.89 $107 24,675 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-28 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −120 0 D
Loading xslF345X05/form4.xml…